Patient
P2B-095
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · State Health Centre Oncology Department (Budapest, Hungary) (Dr. Clarke)
consented 2013-03-30
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
Grade 3 anaemia with onset in cycle 4 (2013-06-28); assessed as related to study drug (probable); resolved 2013-07-05; action: drug withdrawn.
Grade 2 diarrhoea with onset in cycle 4 (2013-06-19); assessed as not related to study drug (unlikely); resolved 2013-06-22.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.